Tracking Japan’s development assistance for health, 2012–2016
Abstract Background Development assistance for health (DAH) is one of the most important means for Japan to promote diplomacy with developing countries and contribute to the international community. This study, for the first time, estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-04-01
|
| Series: | Globalization and Health |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12992-020-00559-2 |
| _version_ | 1818478861171556352 |
|---|---|
| author | Shuhei Nomura Haruka Sakamoto Maaya Kita Sugai Haruyo Nakamura Keiko Maruyama-Sakurai Sangnim Lee Aya Ishizuka Kenji Shibuya |
| author_facet | Shuhei Nomura Haruka Sakamoto Maaya Kita Sugai Haruyo Nakamura Keiko Maruyama-Sakurai Sangnim Lee Aya Ishizuka Kenji Shibuya |
| author_sort | Shuhei Nomura |
| collection | DOAJ |
| description | Abstract Background Development assistance for health (DAH) is one of the most important means for Japan to promote diplomacy with developing countries and contribute to the international community. This study, for the first time, estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and clarified its flows, including source, aid type, channel, target region, and target health focus area. Methods Data on Japan Tracker, the first data platform of Japan’s DAH, were used. The DAH definition was based on the Organisation for Economic Co-operation and Development’s (OECD) sector classification. Regarding core funding to non-health-specific multilateral agencies, we estimated DAH and its flows based on the OECD methodology for calculating imputed multilateral official development assistance (ODA). Results Japan’s DAH was estimated at 1472.94 (2012), 823.15 (2013), 832.06 (2014), 701.98 (2015), and 894.57 million USD (2016) in constant prices of 2016. Multilateral agencies received the largest DAH share of 44.96–57.01% in these periods, followed by bilateral grants (34.59–53.08%) and bilateral loans (1.96–15.04%). Ministry of Foreign Affairs (MOFA) was the largest contributors to the DAH (76.26–82.68%), followed by Ministry of Finance (MOF) (10.86–16.25%). Japan’s DAH was most heavily distributed in the African region with 41.64–53.48% share. The channel through which the most DAH went was Global Fund to Fight AIDS, Tuberculosis, and Malaria (20.04–34.89%). Between 2012 and 2016, approximately 70% was allocated to primary health care and the rest to health system strengthening. Conclusions With many major high-level health related meetings ahead, coming years will play a powerful opportunity to reevaluate DAH and shape the future of DAH for Japan. We hope that the results of this study will enhance the social debate for and contribute to the implementation of Japan’s DAH with a more efficient and effective strategy. |
| first_indexed | 2024-12-10T09:53:27Z |
| format | Article |
| id | doaj.art-d657a93bba944c3d817411a8aeafb99e |
| institution | Directory Open Access Journal |
| issn | 1744-8603 |
| language | English |
| last_indexed | 2024-12-10T09:53:27Z |
| publishDate | 2020-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Globalization and Health |
| spelling | doaj.art-d657a93bba944c3d817411a8aeafb99e2022-12-22T01:53:36ZengBMCGlobalization and Health1744-86032020-04-0116111210.1186/s12992-020-00559-2Tracking Japan’s development assistance for health, 2012–2016Shuhei Nomura0Haruka Sakamoto1Maaya Kita Sugai2Haruyo Nakamura3Keiko Maruyama-Sakurai4Sangnim Lee5Aya Ishizuka6Kenji Shibuya7Department of Global Health Policy, Graduate School of Medicine, The University of TokyoDepartment of Global Health Policy, Graduate School of Medicine, The University of TokyoDepartment of Global Health Policy, Graduate School of Medicine, The University of TokyoDepartment of Global Health Policy, Graduate School of Medicine, The University of TokyoInstitute for Global Health Policy Research (iGHP), Bureau of International Health Cooperation, National Center for Global Health and MedicineDisease Control and Prevention Center, National Center for Global Health and MedicineDepartment of Global Health Policy, Graduate School of Medicine, The University of TokyoDepartment of Global Health Policy, Graduate School of Medicine, The University of TokyoAbstract Background Development assistance for health (DAH) is one of the most important means for Japan to promote diplomacy with developing countries and contribute to the international community. This study, for the first time, estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and clarified its flows, including source, aid type, channel, target region, and target health focus area. Methods Data on Japan Tracker, the first data platform of Japan’s DAH, were used. The DAH definition was based on the Organisation for Economic Co-operation and Development’s (OECD) sector classification. Regarding core funding to non-health-specific multilateral agencies, we estimated DAH and its flows based on the OECD methodology for calculating imputed multilateral official development assistance (ODA). Results Japan’s DAH was estimated at 1472.94 (2012), 823.15 (2013), 832.06 (2014), 701.98 (2015), and 894.57 million USD (2016) in constant prices of 2016. Multilateral agencies received the largest DAH share of 44.96–57.01% in these periods, followed by bilateral grants (34.59–53.08%) and bilateral loans (1.96–15.04%). Ministry of Foreign Affairs (MOFA) was the largest contributors to the DAH (76.26–82.68%), followed by Ministry of Finance (MOF) (10.86–16.25%). Japan’s DAH was most heavily distributed in the African region with 41.64–53.48% share. The channel through which the most DAH went was Global Fund to Fight AIDS, Tuberculosis, and Malaria (20.04–34.89%). Between 2012 and 2016, approximately 70% was allocated to primary health care and the rest to health system strengthening. Conclusions With many major high-level health related meetings ahead, coming years will play a powerful opportunity to reevaluate DAH and shape the future of DAH for Japan. We hope that the results of this study will enhance the social debate for and contribute to the implementation of Japan’s DAH with a more efficient and effective strategy.http://link.springer.com/article/10.1186/s12992-020-00559-2Development assistance for healthHealth policyJapan |
| spellingShingle | Shuhei Nomura Haruka Sakamoto Maaya Kita Sugai Haruyo Nakamura Keiko Maruyama-Sakurai Sangnim Lee Aya Ishizuka Kenji Shibuya Tracking Japan’s development assistance for health, 2012–2016 Globalization and Health Development assistance for health Health policy Japan |
| title | Tracking Japan’s development assistance for health, 2012–2016 |
| title_full | Tracking Japan’s development assistance for health, 2012–2016 |
| title_fullStr | Tracking Japan’s development assistance for health, 2012–2016 |
| title_full_unstemmed | Tracking Japan’s development assistance for health, 2012–2016 |
| title_short | Tracking Japan’s development assistance for health, 2012–2016 |
| title_sort | tracking japan s development assistance for health 2012 2016 |
| topic | Development assistance for health Health policy Japan |
| url | http://link.springer.com/article/10.1186/s12992-020-00559-2 |
| work_keys_str_mv | AT shuheinomura trackingjapansdevelopmentassistanceforhealth20122016 AT harukasakamoto trackingjapansdevelopmentassistanceforhealth20122016 AT maayakitasugai trackingjapansdevelopmentassistanceforhealth20122016 AT haruyonakamura trackingjapansdevelopmentassistanceforhealth20122016 AT keikomaruyamasakurai trackingjapansdevelopmentassistanceforhealth20122016 AT sangnimlee trackingjapansdevelopmentassistanceforhealth20122016 AT ayaishizuka trackingjapansdevelopmentassistanceforhealth20122016 AT kenjishibuya trackingjapansdevelopmentassistanceforhealth20122016 |